Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid
This case report describes a patient with immune checkpoint inhibitor–associated bullous pemphigoid and preexisting anti-BP180–C-terminus antibodies.
Related Articles
Advancing Pediatric Atopic Dermatitis Care: Challenges, Innovations, and Future Directions
This news content has been independently developed and is not endorsed by the American Academy of Dermatology: Lisa Swanson, MD, FAAD; Aaron Farberg, MD; James…
Q&A: Peter Lio, MD, on Safety in Pediatric AD Management and the Promise of Precision Medicine
Discover insights from Peter Lio, MD, on precision medicine in pediatric atopic dermatitis and the promising role of ruxolitinib at the RAD 2025 Conference.
Addictive Screen Use Trajectories and Suicidal Behaviors, Suicidal Ideation, and Mental Health in US Youths
This cohort study identifies trajectories of addictive use of social media, mobile phones, and video games among US youths and examines their associations with suicidal…
Alys Pharmaceuticals Submits ALY-301 Clinical Trial Application in Germany for Cold Urticaria
Alys plans to conduct a phase 1/1b trial assessing the efficacy and safety of the mast cell selective c-Kit inhibitor in the CIndU subtype.
Clinical Pearls from the 2025 Fall Clinical PA/NP Meeting: Day 1
Jamie Restivo, MPAS, PA-C, shares her key takeaways from the first day of the recent Fall Clinical PA/NP Conference in Orlando, Florida.
Basics of Rosacea
Rosacea is a complex condition that often presents as a combination of subtypes rather than a single distinct form. This discussion highlights the shift from…
Diagnosing and Managing GPP: Top Insights From the Experts
Aaron Farberg, MD, led a panel exploring the challenges of diagnosing and treating generalized pustular psoriasis and the promise of targeted therapies.
Journal Digest: June 18, 2025
This review of the latest dermatologic studies includes insights into differences in vitamin D levels in rosacea versus healthy individuals, psychosocial determinants and atopic dermatitis…
Use of Intravenous Albumin
This JAMA Clinical Guidelines Synopsis summarizes the 2024 guidelines on use of intravenous albumin from the International Collaboration for Transfusion Medicine.
Psoriasis Risk in Patients With Atopic Dermatitis Treated With Dupilumab
This cohort study examines psoriasis risk in patients with atopic dermatitis who are prescribed dupilumab vs other systemic agents.